Koudeláková Vladimíra Ph.D.
Journals
BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy.
Tumor Biology.
2015,
36(6),
4243-52,
ISSN: 1010-4283,
PMID: 25616695,
Isocitrate dehydrogenase 1 and 2 mutations in gliomas.
Journal of Neuroscience Research.
2014,
92(12),
1611-1620,
ISSN: 0360-4012,
PMID: 25078896,
Non-small cell lung cancer - genetic predictors.
Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic.
2013,
157(2),
125-136,
ISSN: 1213-8118,
PMID: 23733083,
Open positions
Project: | Genetic and epigenetic biomarkers in health and disease |
---|---|
Supervisors: | Slavkovský Rastislav Ph.D., Džubák Petr M.D., Ph.D., Hajdúch Marián M.D., Ph.D., Drábek Jiří Ph.D., Koudeláková Vladimíra Ph.D. |
Available: | 5 |
Intended for: | Doctoral training |
Project: | Prognostic biomarkers in glial tumors |
---|---|
Supervisors: | Koudeláková Vladimíra Ph.D. |
Available: | 1 |
Intended for: | Bachelor training |
Summary: | - |